Edwards Lifesciences Corp
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -11.2% | -13.9% | +1.7% | +22.2% | +8.3% | +7.1% | +3.9% | +5.2% | +13.4% | +6.8% | +9.5% | +16.0% | +13.2% | +7.7% | +13.6% | +7.4% | +18.8% | +15.9% | +8.4% | +16.8% | +0.9% | +19.3% | +2.9% | +11.6% | -9.4% | +11.5% | |
| – | -9.2% | -23.4% | -7.7% | +20.2% | +3.0% | +1.2% | +2.3% | -0.5% | +7.2% | -2.4% | +2.8% | +12.4% | +10.0% | +7.3% | +16.1% | +8.4% | +17.8% | +9.6% | +4.4% | +25.3% | -4.9% | +11.5% | -4.8% | +18.2% | -19.0% | +18.7% | |
| – | -13.2% | -3.4% | +10.0% | +23.8% | +12.0% | +11.0% | +4.9% | +8.6% | +16.8% | +11.3% | +12.4% | +17.4% | +14.4% | +7.8% | +12.7% | +7.0% | +19.3% | +18.3% | +9.7% | +14.0% | +3.0% | +21.9% | +5.2% | +9.7% | -6.6% | +9.7% | |
| – | +0.0% | +0.0% | +18.5% | +11.7% | +19.5% | +13.8% | +15.4% | +7.1% | +13.8% | +26.1% | +16.5% | +20.5% | +18.3% | +10.9% | +7.3% | +10.6% | +15.4% | +25.0% | +12.6% | +21.0% | +1.1% | +18.7% | +4.7% | +13.4% | -1.8% | +2.5% | |
| – | -7.3% | -6.0% | +12.3% | +27.2% | +10.3% | +9.0% | +7.8% | +11.2% | +15.0% | +5.9% | +8.1% | +16.8% | +9.8% | +5.7% | +15.1% | -0.9% | +6.3% | +8.8% | +10.5% | +14.1% | -1.1% | +21.6% | +4.9% | +12.1% | +1.9% | +16.5% | |
| – | -11.2% | +20.3% | +2.6% | +2.8% | +12.2% | +10.0% | +9.5% | +10.2% | +14.7% | +10.4% | +10.2% | +17.8% | +12.1% | +7.3% | +12.7% | +2.4% | +8.8% | +14.9% | +10.8% | +16.8% | -0.2% | +20.3% | +4.9% | +15.3% | +1.6% | +5.5% | |
| – | -18.8% | -74.7% | +117.1% | +165.6% | +11.6% | +13.7% | -6.9% | +3.7% | +23.3% | +13.9% | +18.7% | +16.5% | +20.5% | +9.2% | +12.5% | +18.2% | +41.6% | +23.9% | +8.1% | +9.7% | +8.2% | +24.3% | +5.7% | -9.9% | -10.1% | +18.7% | |
| – | – | – | -50.0% | +14.8% | +7.6% | -13.4% | -14.6% | -13.3% | -20.9% | -84.7% | +118.2% | +29.2% | +41.9% | +31.8% | +272.4% | -14.8% | -2.2% | +28.9% | +44.0% | -18.3% | -18.7% | +11.7% | +5.6% | -32.8% | +12.5% | +3.0% | |
| – | -329.2% | – | – | +65.7% | -67.6% | +287.7% | +47.6% | -13.1% | +9.7% | +85.2% | -11.9% | +5.7% | +37.9% | +31.8% | +122.0% | -45.6% | +18.6% | +40.2% | -26.4% | +53.2% | -21.4% | +85.7% | +3.8% | -9.6% | -3.1% | -17.8% | |
| – | -58.1% | -92.3% | -70.0% | +4,500.0% | +105.8% | +31.7% | +11.8% | -12.0% | -3.5% | +112.1% | -33.3% | -6.6% | +108.7% | +26.3% | +169.3% | -61.7% | +32.1% | +168.0% | -91.3% | +205.1% | -22.0% | +113.2% | +23.4% | -19.1% | -23.5% | +42.6% | |
| – | -431.7% | – | – | +41.8% | -97.8% | +4,564.7% | +64.6% | -13.4% | +14.1% | +77.7% | -4.8% | +8.6% | +23.9% | +33.6% | +107.1% | -39.0% | +15.1% | +9.2% | +16.1% | +45.0% | -21.3% | +82.5% | +1.3% | -7.9% | +197.7% | -74.3% | |
| – | -15.9% | -52.0% | +14.1% | +98.9% | -45.7% | +85.2% | +29.4% | -10.8% | +6.3% | +30.6% | +10.2% | +5.4% | +31.4% | +30.3% | +109.3% | -42.7% | +17.1% | +37.8% | -23.5% | +50.0% | -17.9% | +75.9% | +3.7% | -21.7% | +12.3% | -17.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.